NSAID activated gene (NAG-1), a modulator of tumorigenesis

Journal of Biochemistry and Molecular Biology

Volumn 39, Issue 6, 2006, Pages 649-655

  Eling, Thomas E ^a   Baek, Seung Joon ^b   Shim, Minsub ^a   Lee, Chang Ho ^c  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c Gangneung Wonju National University   (South Korea)

Author keywords

Anti tumorigenic; Cancer; Cox inhibitor; Min mice; NAG 1; Tumor suppressor

Indexed keywords

MUS MUSCULUS;

EID: 33845397898     PISSN: 12258687     EISSN: 12258687     Source Type: Journal    
DOI: 10.5483/bmbrep.2006.39.6.649     Document Type: Review

References (45)

1. Albertoni, M., Shaw, P. H., Nozaki, M., Godard, S., Tenan, M., Hamou, M. F., Fairlie, D. W., Breit, S. N., Paralkar, V. M., de Tribolet, N., Van Meir, E. G. and Hegi, M. E. (2002) Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 21, 4212-4219.
2. Baek, S. J. and Eling, T. E. (2006a) Changes in gene expression contribute to cancer prevention by COX inhibitors. Prog. Lipid Res. 45, 1-16.
3. Baek, S. J., Horowitz, J. M. and Eling, T. E. (2001a) Molecular cloning and characterization of human nonsteroidal antiinflammatory drug-activated gene promoter. Basal transcription is mediated by Spl and Sp3. J. Biol. Chem. 276, 33384-33392.
4. Baek, S. J., Kim, J. S., Moore, S. M., Lee, S. H., Martinez, J. and Eling, T. E. (2005) Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol. Pharmacol. 67, 356-364.
5. Baek, S. J., Kim, J. S., Nixon, J. B., DiAugustine, R. P. and Eling, T. E. (2004) Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. J. Biol. Chem. 279, 6883-6892.
6. Baek, S. J., Kim, K. S., Nixon, J. B., Wilson, L. C. and Eling, T. E. (2001 b). Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol. Pharmacol. 59, 901-908.
7. Baek, S. J., Okazaki, R., Lee, S. H., Martinez, J., Kim, J. S., Yamaguchi, K., Mishina, Y., Martin, D. W., Shoieb, A., McEntee, M. F. and Eling, T. E. (2006b) Nonsteroidal anti-inflammatory drug activated gene-1 overexpression in transgenic mice suppresses intestinal neoplasia. Gastroenterology in press.
8. Baek, S. J., Wilson, L. C. and Eling, T. E. (2002a) Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis 23, 425-432.
9. Baek, S. J., Wilson, L. C., Lee, C. H. and Eling, T. E. (2002b) Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene. J. Pharmacol. Exp. Ther. 301, 1126-1131.
10. Bauskin, A. R., Brown, D. A., Junankar, S., Rasiah, K. K., Eggleton, S., Hunter, M., Liu, T., Smith, D., Kuffher, T., Pankhurst, G J. et al. (2005) The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Res. 65, 2330-2336.
11. Bauskin, A. R., Zhang, H. P., Fairlie, W. D., He, X. Y., Russell, P. K., Moore, A. G., Brown, D. A., Stanley, K. K. and Breit, S. N. (2000) The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. Embo J. 19, 2212-2220.
12. Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S., Pryor, K., Walsh, B. J., Nicholson, R. C., Fairlie, W. D., Por, S. B, Robbins, J. M. and Breit, S. N. (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc. Natl. Acad. Sci. USA 94, 11514-11519.
13. Bottner, M., Suter-Crazzolara, C., Schober, A. and Unsicker, K. (1999) Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophageinhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res 297, 103-110.
14. Bottone, F. G., Jr., Baek, S. J., Nixon, J. B. and Eling, T. E. (2002) Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells. J. Nutr. 132, 773-778.
15. Brown, D. A., Ward, R. L., Buckhaults, P., Liu, T., Romans, K. E., Hawkins, N. J., Bauskin, A. R., Kinzler, K. W., Vogelstein, B. and Breit, S. N. (2003) MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin. Cancer Res. 9, 2642-2650.
16. Detmer, K., Steele, T. A., Shoop, M. A. and Dannawi, H. (1999). Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines. Blood Cells Mol. Dis. 25, 310-323.
17. Fairlie, W. D., Russell, P. K., Wu, W. M., Moore, A. G., Zhang, H. P., Brown, P. K., Bauskin, A. R. and Breit, S. N. (2001) Epitope mapping of the transforming growth factor-beta superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): identification of at least five distinct epitope specificities. Biochemistry 40, 65-73.
18. Fearon, E. R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell 61, 759-767.
19. Hayes, V. ML, Severi, G., Southey, M. C., Padilla, E. J., English, D. R., Hopper, J. L. Giles, G. G. and Sutherland, R. L. (2006) Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival. Cancer Epidemiol. Biomarkers Prev. 15, 1223-1225.
20. Hsiao, E. C., Koniaris, L. G., Zimmers-Koniaris, T., Sebald, S. M., Huynh, T. V. and Lee, S. J. (2000) Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol. Cell. Biol. 20, 3742-3751.
21. Karan, D., Chen, S. J., Johansson, S. L., Singh, A. P., Paralkar, V. M., Lin, M. F. and Batra, S. K. (2003) Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochem. Biophys. Res. Commun. 305, 598-604.
22. Kim, K. S., Baek, S. J., Flake, G. P., Loftin, C. D., Calvo, B. F. and Eling, T. E. (2002). Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue. Gastroenterology 122, 1388-1398.
23. Kim, K. S., Shin, J. H., Baek, S. J. and Yoon, J. H. (2003) Expression of non-steroidal anti-inflammatory drug-activated gene-1 in human nasal mucosa and cultured nasal epithelial cells: a preliminary investigation. Acta Otolaryngol. 123, 857-861.
24. Kim, K. S., Yoon, J. H., Kim, J. K., Baek, S. J., Eling, T. E., Lee, W. J., Ryu, J. H., Lee, J. G., Lee, J. H. and Yoo, J. B. (2004) Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of nonsteroidal antiinflammatory drug-activated gene. Biochem. Biophys. Res. Commun. 325, 1298-1303.
25. Kinzler, K. W., Nilbert, M. C., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hamilton, S. R., Hedge, P., Markham, A. and et al. (1991) Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 251, 1366-1370.
26. Kinzler, K. W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87, 159-170.
27. Lambert, J. R., Kelly, J. A., Shim, M., Huffer, W. E., Nordeen, S. K., Baek, S. J., Eling, T. E. and Lucia, M. S. (2006) Prostate derived factor in human prostate cancer cells: Gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth. J. Cell. Physiol. 208, 566-574.
28. Lawton, L. N., Bonaldo, M. F., Jelenc, P. C., Qiu, L., Baumes, S. A., Marcelino, R. A., Jesus, G. M., Wellington, S., Knowles, J. A., Warburton, D., Brown, S. and Scares, M. B. (1997) Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta. Gene 203, 17-26.
29. Lee, D. H., Yang, Y., Lee, S. J., Kim, K. Y., Koo, T. H., Shin, S. M., Song, K. S., Lee, Y. H., Kim, Y. J., Lee, J. J., Choi, I., Lee, J. H. (2003) Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Cancer Res. 63, 4648-4655.
30. Lee, S. H., Kim, J. S., Yamaguchi, K., Eling, T. E. and Baek, S. J. (2005) Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent manner. Biochem. Biophys. Res. Commun. 328, 63-69.
31. Lee, S. H., Yamaguchi, K., Kim, J. S., Eling, T. E., Safe, S., Park, Y. and Baek, S. J. (2006) Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner. Camnogenesis 27, 972-981.
32. Li, P. X., Wong, J., Ayed, A., Ngo, D., Brade, A. M., Arrowsmith, C., Austin, R. C. and Klamut, H. J. (2000) Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J. Biol. Chem. 275, 20127-20135.
33. Lindmark, F., Zheng, S. L., Wiklund, F., Bensen, J., Balter, K. A., Chang, B., Hedelin, M., Clark, J., Stattin, P., Meyers, D. A., Adami, H. O, Isaacs, W., Grönberg, H. and Xu, J. (2004) H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J. Natl. Cancer Inst. 96, 1248-1254.
34. Liu, T., Bauskin, A. R., Zaunders, J., Brown, D. A., Pankhurst, S., Russell, P. J. and Breit, S. N. (2003) Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res. 63, 5034-5040.
35. Martinez, J. M., Sali, T., Okazaki, R., Anna, C., Hollingshead, M., Hose, C., Monks, A., Walker, N. J., Baek, S. J. and Eling, T. E. (2006) Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene/macrophage inhibitory cytokine-1/prostate-derived factor, a putative tumor suppressor, inhibits tumor growth. J. Pharmacol Exp. Ther. 318, 899-906.
36. Newman, D., Sakaue, M., Koo, J. S., Kim, K. S., Baek, S. J., Eling, T. and Jetten, A. M. (2003) Differential regulation of nonsteroidal anti-inflammatory drug-activated gene in normal human tracheobronchial epithelial and lung carcinoma cells by retinoids. Mol Pharmacol. 63, 557-564.
37. Paralkar, V. M., Vail, A. L., Grasser, W. A., Brown, T. A., Xu, H., Vukicevic, S., Ke, H. Z., Qi, H., Owen, T. A. and Thompson, D. D. (1998) Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family. J. Biol. Chem. 273, 13760-13767.
38. Shim, M. and Eling, T. E. (2005). Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells. J. Biol. Chem. 280, 18636-18642.
39. Tan, M., Wang, Y., Guan, K. and Sun, Y. (2000) PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proc. Natl. Acad. Sci. USA 97, 109-114.
40. Thomas, R., True, L. D., Lange, P. H. and Vessella, R. L. (2001) Placental bone morphogenetic protein (PLAB) gene expression in normal, pre-malignant and malignant human prostate: relation to tumor development and progression. Int. J. Cancer 93, 47-52.
41. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M. and Bos, J. L. (1988) Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525-532.
42. Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang-Rodriguez, J., Moskaluk, C. A., Frierson, H. F., Jr. and Hampton, G. M. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61, 5974-5978.
43. Wilson, L. C., Baek, S. J., Call, A. and Eling, T. E. (2003) Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int. J. Cancer 105, 747-753.
44. Yamaguchi, K., Lee, S. H., Eling, T. E. and Baek, S. J. (2004). Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3beta pathway. J. Biol. Chem. 279, 49617-49623.
45. Yamaguchi, K., Lee, S. H., Eling, T. E. and Baek, S. J. (2006). A novel peroxisome proliferator-activated receptor gamma ligand, MCC-555, induces apoptosis via posttranscriptional regulation of NAG-1 in colorectal cancer cells. Mol. Cancer Ther. 5, 1352-1361.